AP
Alexion Pharmaceuticals
Has won 4 UK public-sector contracts worth £47.7m across 2 buyers, primarily NHS England and medical equipment work.
Active contracts
3
no new awards in 30d
Contracted (12m)
£47.0m
new
Public buyers
2
stable this month
Top buyer share
98%
NHS England
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 98% of revenue.
NHS England
£47.0m
98%BIRMINGHAM CHILDRENS HOSPITAL
£780k
2%Contracts won · 4 total · 3 active · 1 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Shared contract | £47.0m lot total · 21 suppliers | 01 Jul 2025 | active |
| Pharmacy | BIRMINGHAM CHILDRENS HOSPITAL | Direct contract | £780k | 04 Jun 2018 | expired |
| NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025 | NHS England | Direct contract | — | — | active |
| NHS National Framework for Natalizumab-February 2024 | NHS England | Direct contract | — | — | active |
Top buyers · by total award value
Who this supplier sells to.